doi:10.1056/NEJMoa2301972 PubMed: This landmark study demonstrated 24.2% mean weight loss at 48 weeks with the 12mg dose in 338 adults with obesity, establishing retatrutide as the most effective obesity medication tested to date
The new Wegovy pill is a clinically approved, once-daily tablet, available in the UK from The Independent Pharmacy
This dual-action combination helps improve heart function, reduce fluid buildup, and enhance the pet's quality of life
Live well Refine Prescribing Feel supported Wait less Experience more
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for several indications: type 2 diabetes mellitus, chronic weight management, and more recently, to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either overweight or obesity
Importantly, this study represents the first comparative transcriptomic analysis of semaglutide and tirzepatide in BAT, identifying key gene targets through RNA sequencing and RT-qPCR validation, and providing novel insights into their potential roles in mediating energy metabolism and insulin sensitivity
